**Core Concept**
Theophylline is a methylxanthine derivative with bronchodilatory properties, primarily used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It acts as a phosphodiesterase inhibitor, which increases intracellular cyclic AMP (cAMP) levels, leading to smooth muscle relaxation and bronchodilation.

**Why the Correct Answer is Right**
Theophylline's mechanism of action involves inhibition of phosphodiesterase (PDE) enzymes, specifically PDE3 and PDE4, which are responsible for the breakdown of cAMP. By inhibiting these enzymes, theophylline increases intracellular cAMP levels, leading to activation of protein kinase A (PKA) and subsequent relaxation of smooth muscle cells in the airways. This results in bronchodilation and improved respiratory function in patients with asthma and COPD.

**Why Each Wrong Option is Incorrect**
**Option A:** Theophylline is not a selective beta-2 adrenergic receptor agonist, unlike other bronchodilators such as salbutamol.
**Option B:** Theophylline's primary mechanism of action is not through inhibition of the enzyme cyclooxygenase (COX), which is involved in the synthesis of prostaglandins.
**Option C:** Theophylline is not primarily metabolized by the cytochrome P450 enzyme CYP2C19; it is primarily metabolized by CYP1A2 and CYP3A4.

**Clinical Pearl / High-Yield Fact**
Theophylline has a narrow therapeutic index, and its plasma concentrations must be carefully monitored to avoid toxicity, which can manifest as nausea, vomiting, and seizures.

**Correct Answer:** C.